Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
168.63x
As of Mar 28, 2025
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Mar 28, 2025 | 168.63x |
| Mar 27, 2025 | 168.75x |
| Mar 26, 2025 | 167.67x |
| Mar 25, 2025 | 159.95x |
| Mar 24, 2025 | 163.57x |
| Mar 21, 2025 | 169.35x |
| Mar 20, 2025 | 163.45x |
| Mar 19, 2025 | 155.49x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison